Literature DB >> 11681853

Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.

I G Obrosova1, L Fathallah, M J Stevens.   

Abstract

Oxidative stress has a key role in the pathogenesis of diabetic complications. We have previously reported that taurine (T), which is known to counteract oxidative stress in tissues (lens, kidney, retina) of diabetic rats, attenuates nerve blood flow and conduction deficits in early experimental diabetic neuropathy (EDN). The purpose of this study was to evaluate whether dietary T supplementation counteracts oxidative stress and the nerve growth factor (NGF) deficit in the diabetic peripheral nerve. The experiments were performed in control rats and streptozotocin-diabetic rats fed standard or 1% T-supplemented diets for 6 weeks. All measurements were performed in the sciatic nerve. Malondialdehyde (MDA) plus 4-hydroxyalkenals (4-HA) were quantified with N-methyl-2-phenylindole. GSH, GSSG, dehydroascorbate (DHAA), and ascorbate (AA) were assayed spectrofluorometrically, T by reverse-phase HPLC, and NGF by ELISA. MDA plus 4-HA concentration (mean +/- SEM) was increased in diabetic rats (0.127 +/- 0.006 vs 0.053 +/- 0.003 micromol/g in controls, P < 0.01), and this increase was partially prevented by T (0.096 +/- 0.004, P < 0.01 vs untreated diabetic group). GSH levels were similarly decreased in diabetic rats treated with or without taurine vs controls. GSSG levels were similar in control and diabetic rats but were lower in diabetic rats treated with T (P < 0.05 vs controls). AA levels were decreased in diabetic rats (0.133 +/- 0.015 vs 0.219 +/- 0.023 micromol/g in controls, P < 0.05), and this deficit was prevented by T. DHAA/AA ratio was increased in diabetic rats vs controls (P < 0.05), and this increase was prevented by T. T levels were decreased in diabetic rats (2.7 +/- 0.16 vs 3.8 +/- 0.1 micromol/g in controls, P < 0.05) and were repleted by T supplementation (4.2 +/- 0.3). NGF levels were decreased in diabetic rats (2.35 +/- 0.20 vs 3.57 +/- 0.20 ng/g in controls, P < 0.01), and this decrease was attenuated by T treatment (3.16 +/- 0.28, P < 0.05 vs diabetic group). In conclusion, T counteracts oxidative stress and the NGF deficit in early EDN. Antioxidant effects of T in peripheral nerve are, at least in part, mediated through the ascorbate system of antioxidative defense. The findings are consistent with the important role for oxidative stress in impaired neurotrophic support in EDN. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681853     DOI: 10.1006/exnr.2001.7789

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  29 in total

Review 1.  Oxidative stress and diabetic neuropathy: a new understanding of an old problem.

Authors:  Eva L Feldman
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

3.  Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.

Authors:  Xia Liu; Fang Zhong; Xu-long Tang; Fu-lin Lian; Qiao Zhou; Shan-mai Guo; Jia-fu Liu; Peng Sun; Xu Hao; Ying Lu; Wei-ming Wang; Nan Chen; Nai-xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-03-17       Impact factor: 6.150

Review 4.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

Review 5.  Ameliorative effects of taurine against diabetes: a review.

Authors:  Fengyuan Piao; Rana Muhammad Aadil; Raheel Suleman; Kaixin Li; Mengren Zhang; Pingan Wu; Muhammad Shahbaz; Zulfiqar Ahmed
Journal:  Amino Acids       Date:  2018-02-28       Impact factor: 3.520

6.  Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial.

Authors:  R Pop-Busui; M J Stevens; D M Raffel; E A White; M Mehta; C D Plunkett; M B Brown; E L Feldman
Journal:  Diabetologia       Date:  2013-06-06       Impact factor: 10.122

Review 7.  Future treatments for diabetic neuropathy: clues from experimental neuropathy.

Authors:  Nigel A Calcutt
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

8.  Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

Review 9.  Is taurine beneficial in reducing risk factors for diabetes mellitus?

Authors:  Flavia Franconi; Mauro A S Di Leo; Federico Bennardini; Giovanni Ghirlanda
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 10.  Age-related retinal degeneration in animal models of aging: possible involvement of taurine deficiency and oxidative stress.

Authors:  Julius Militante; John B Lombardini
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.